Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALT-D: Crofelemer for Chemotherapy-Induced Diarrhea
NCT02910219Phase 2Completed
- Sponsor
- Sandra Swain
- Start
- Jan 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of crofelemer in diarrhea (2 arms), sponsored by Sandra Swain. Primary endpoint: Incidence of Diarrhea for >= 2 Consecutive Days at Cycle 2. Started Jan 2017; status: completed.
02
Drugs
crofelemer
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02910219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910219.